Hui Zhang

Dr. Hui Zhang


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2020 in Acta Pharmaceutica Sinica B
Verified
Journal Article
Open access
LLLu Luo
Lu Luo
JJJingwen Jiang
Jingwen Jiang
CWCheng Wang
Cheng Wang
MFMartin Fitzgerald
Martin Fitzgerald
WHWeifeng Hu
Weifeng Hu
SCShilin Chen
Shilin Chen
As coronavirus disease 2019 (COVID-19) pandemic poses a substantial global public health threat, traditional Chinese medicine (TCM) was used in 91.50% of the COVID-19 cases in China, showing encouraging results in improving symptom management and reducing the deterioration, mortality, and recurrence rates. A total of 166 modified herbal formulae consisting of 179 single herbal medicines were collected for treating COVID-19 in China. Glycyrrhizae Radix et Rhizome, Scutellariae Radix, and Armeniacae Semen Amarum are the most frequently utilized in clinics, most of which are antipyretic (47, 26.26%), expectorant and cough-suppressing (22, 12.29%), and dampness-resolving (21, 11.73%) from traditional descriptions. A total of 1212 chemical components containing β-sitosterol, stigmasterol, and quercetin were primarily selected. Additionally, using complex system entropy and unsupervised hierarchical clustering, 8 core herbal combinations and 10 new formulae emerged as potentially useful candidates for COVID-19. Finally, following scaffold analysis, self-organizing mapping (SOM) and cluster analysis, 12 clusters of molecules yielded 8 pharmacophore families of structures that were further screened as pharmacological targets in human metabolic pathways for inhibiting coronavirus. This article aims to make more easily accessible and share historical herbal knowledge used in contemporary treatments in a modern manner to assist researchers contain the global spread of COVID-19.

7 January 2010 in Molecular BioSystems
Verified
Journal Article
Closed access
PDF file
TMTao Ma
Tao Ma
CTConge Tan
Conge Tan
HZHui Zhang
Hui Zhang
MWMiqu Wang
Miqu Wang
WDWeijun Ding
Weijun Ding
Shao LiShao Li
Shao Li
Systems biology is a general trend of contemporary scientific development. When coupling the classical traditional Chinese medicine (TCM) Cold Syndrome and methodology of systems biology, we conformed to the genome, transcriptome, proteome, and metabolome that are supposed to run through the overall macro behavior, and explored the macro and micro framework of systems biology of TCM Syndrome. We introduced a new way to probe into the implicit stratification of Cold Syndrome, after surveying 4575 cases of Cold Syndrome patients and examining gene expression information of a typical Cold Syndrome pedigree by microarray. We underlined the genetic background of the Cold Syndrome family based on the molecular foundation to understand Syndrome, one of our earlier discoveries in which genes and chemical compounds in neuro-endocrine-immune (NEI) system are scored as Cold or Hot (or both) property. Results indicate that Cold Syndrome related genes play an essential role in energy metabolism, which are tightly correlated with the genes of neurotransmitters, hormones and cytokines in the NEI interaction network. Therefore, NEI interaction not only opens out mechanism of classical TCM theory on Syndrome but also enriches current research on complex diseases as well as systems biology.

1 April 2010 in European Journal of Integrative Medicine
Verified
Journal Article
Closed access
HZHui Zhang
Hui Zhang
CTConge Tan
Conge Tan
HWHongzhan Wang
Hongzhan Wang
SXShengbo Xue
Shengbo Xue
MWMiqu Wang
Miqu Wang


25 July 2018 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
PDF file
HZHui Zhang
Hui Zhang
ZWZhuo Wang
Zhuo Wang
RMRong Ma
Rong Ma
JWJianzhong Wu
Jianzhong Wu
JFJi-feng Feng
Ji-feng Feng
Early detection is critical for the treatment of colon carcinoma. However, current biomarkers for its diagnosis and prognosis are insufficient and improvement is required. Aberrantly expressed microRNAs (miRNAs/miRs) in colon carcinoma have been identified to function as potential diagnostic and prognostic biomarkers. In the present study, 245 differentially expressed miRNAs between colon carcinoma and normal tissues were identified by a bioinformatics analysis of a dataset from The Cancer Genome Atlas. A six‑miRNA (miR‑149, miR‑3189, miR‑3677, miR‑3917, miR‑4999 and miR‑6854) prognostic prediction system was established, which is able to independently and effectively predict the prognosis of colon carcinoma patients [P<0.001, area under the receiver operating characteristic curve (AUC)=0.763]. Furthermore, the six miRNAs were highly correlated with the tumor‑nodes‑metastasis (TNM) stage and were able to distinguish between different stages (high vs. low TNM stage, P<0.001). Of note, combination of the six‑miRNA signature and TNM stage provides an improved prediction of the patient's prognosis (AUC=0.797). Functional enrichment analysis revealed the possible mechanistic involvement of these predictive miRNAs in cancer‑associated biological processes and pathways. Taken together, the present study demonstrated the promising potential of the novel six‑miRNA model as an independent factor for the prediction of the progression and prognosis of colon carcinoma.

23 June 2025 in Chinesische Medizin / Chinese Medicine
Verified
Journal Article
Closed access
PDF file
HZHui Zhang
Hui Zhang